|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 38/48 | |
| A61K 47/12 | |||
| A61P 1/00 | |||
| A61P 17/00 | |||
| A61P 37/08 |
| (11) | Patento numeris | 2344183 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 09819568.8 |
| Europos patento paraiškos padavimo data | 2009-10-09 | |
| (97) | Europos patento paraiškos paskelbimo data | 2011-07-20 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2015-02-25 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2009/005535 |
| Data | 2009-10-09 |
| (87) | Numeris | WO 2010/042203 |
| Data | 2010-04-15 |
| (30) | Numeris | Data | Šalis |
| 104607 P | 2008-10-10 | US |
| (72) |
BERNER, Bret, US
|
| (73) |
Alvine Pharmaceuticals, Inc.,
75 Shoreway Road, Suite B, San Carlos, CA 94070,
US
|
| (54) | DOSAGE FORMS THAT FACILITATE RAPID ACTIVATION OF ZYMOGEN |
| DOSAGE FORMS THAT FACILITATE RAPID ACTIVATION OF ZYMOGEN |